- Home
- TCBX vs FDMT Comparison
TCBX vs FDMT Comparison
Compare TCBX & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- FDMT
- Stock Information
- Founded
- TCBX 2008
- FDMT 2013
- Country
- TCBX United States
- FDMT United States
- Employees
- TCBX N/A
- FDMT N/A
- Industry
- TCBX Banks
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- FDMT Health Care
- Exchange
- TCBX Nasdaq
- FDMT Nasdaq
- Market Cap
- TCBX 369.0M
- FDMT 420.7M
- IPO Year
- TCBX 2021
- FDMT 2020
- Fundamental
- Price
- TCBX $34.77
- FDMT $8.23
- Analyst Decision
- TCBX Buy
- FDMT Strong Buy
- Analyst Count
- TCBX 4
- FDMT 9
- Target Price
- TCBX $25.50
- FDMT $46.88
- AVG Volume (30 Days)
- TCBX 62.7K
- FDMT 660.3K
- Earning Date
- TCBX 10-23-2024
- FDMT 11-15-2024
- Dividend Yield
- TCBX N/A
- FDMT N/A
- EPS Growth
- TCBX 38.69
- FDMT N/A
- EPS
- TCBX 2.56
- FDMT N/A
- Revenue
- TCBX $158,911,000.00
- FDMT $20,218,000.00
- Revenue This Year
- TCBX N/A
- FDMT N/A
- Revenue Next Year
- TCBX $6.26
- FDMT $57.85
- P/E Ratio
- TCBX $13.05
- FDMT N/A
- Revenue Growth
- TCBX 17.73
- FDMT 784.81
- 52 Week Low
- TCBX $15.50
- FDMT $7.90
- 52 Week High
- TCBX $34.41
- FDMT $36.25
- Technical
- Relative Strength Index (RSI)
- TCBX 76.73
- FDMT 34.92
- Support Level
- TCBX $33.26
- FDMT $7.98
- Resistance Level
- TCBX $34.41
- FDMT $8.74
- Average True Range (ATR)
- TCBX 1.03
- FDMT 0.44
- MACD
- TCBX 0.24
- FDMT 0.21
- Stochastic Oscillator
- TCBX 97.80
- FDMT 38.78
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company has one segment, community banking, it generates most of its revenue from interest on loans, customer service, and loan fees.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.